Kessler Topaz Meltzer & Check, LLP is Investigating Securities Fraud Claims on Behalf of ChemoCentryx, Inc. (Nasdaq: CCXI) Investors

RADNOR, Pa., May 04, 2021 (GLOBE NEWSWIRE) — The law firm of Kessler Topaz Meltzer & Check, LLP is currently investigating potential violations of the federal securities laws on behalf of shareholders of ChemoCentryx, Inc. (“ChemoCentryx”) (NASDAQ: CCXI).  

ChemoCentryx is a biopharmaceutical company developing new medications for inflammatory and autoimmune diseases and cancer.

On May 4, 2021, the U.S. Food and Drug Administration (“FDA”) released a “Briefing Document” concerning ChemoCentryx’s drug candidate avacopan, which is in development for the treatment of adult patients with anti-neutrophil cytoplasmic autoantibody vasculitis. In the Briefing Document, the FDA stated, “[a]lthough primary efficacy comparisons were statistically significant, the review team has identified several areas of concern, raising uncertainties about the interpretability of the[] data and the clinical meaningfulness of the[] results.”  

Following this news, ChemoCentryx’s stock price is down approximately 45% during intraday trading on May 4, 2021.

If you are a ChemoCentryx investor and would like to learn more about our investigation, please contact Kessler Topaz Meltzer & Check, LLP: James Maro, Esq. (484) 270-1453 or Adrienne Bell, Esq. (484) 270-1435; toll free at (844) 887-9500; via e-mail at [email protected]; or please visit the following link to fill out our online form https://www.ktmc.com/chemocentryx-inc-investigation?utm_source=PR&utm_medium=link&utm_campaign=chemocentryx.

Kessler Topaz Meltzer & Check, LLP prosecutes class actions in state and federal courts throughout the country involving securities fraud, breaches of fiduciary duties and other violations of state and federal law. Kessler Topaz Meltzer & Check, LLP is a driving force behind corporate governance reform, and has recovered billions of dollars on behalf of institutional and individual investors from the United States and around the world.  The firm represents investors, consumers and whistleblowers (private citizens who report fraudulent practices against the government and share in the recovery of government dollars).  For more information about Kessler Topaz Meltzer & Check, LLP, please visit www.ktmc.com.

CONTACT:

Kessler Topaz Meltzer & Check, LLP
James Maro, Jr., Esq.
Adrienne Bell, Esq.
280 King of Prussia Road
Radnor, PA 19087
(844) 887-9500
[email protected]

Wall St Business News, Latest and Up-to-date Business Stories from Newsmakers of Tomorrow